Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer

BACKGROUND: The development of paclitaxel-resistance led to the tumor relapse and treatment failure of non-small cell lung cancer. Shikonin has been demonstrated to show anti-cancer activity in many cancer types. The present study aimed to investigate the anti-cancer activity of shikonin in paclitax...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Farong, Rao, Yuanquan, Zhu, Xinhai, Wu, Zhibing, Jiang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140387/
https://www.ncbi.nlm.nih.gov/pubmed/32268876
http://dx.doi.org/10.1186/s10020-020-00152-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140387/
https://www.ncbi.nlm.nih.gov/pubmed/32268876
http://dx.doi.org/10.1186/s10020-020-00152-8

Ejemplares similares